News

ASX Announcement: Green Whistle receives regulatory and marketing approval in the United Kingdom

Oct 28, 2015Cathy WilsonNews

28 October 2015

ASX ANNOUNCEMENT

Green Whistle receives regulatory and marketing approval in the United Kingdom

Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received final approval from the Medicines and Healthcare Products Regulatory Agency (MHRA)? to market and sell its inhaled analgesic product, ?Penthrox? indicated for trauma and associated pain, in the United Kingdom.

To read the full announcement click on the following link: ?Penthrox receives regulatory and marketing approval in the UK?

'),document.contains||document.write(''),window.DOMRect||document.write(''),window.URL&&window.URL.prototype&&window.URLSearchParams||document.write(''),window.FormData&&window.FormData.prototype.keys||document.write(''),Element.prototype.matches&&Element.prototype.closest||document.write('')